These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 21945253

  • 1. Preparation and immunological effectiveness of a swine influenza DNA vaccine encapsulated in chitosan nanoparticles.
    Zhao K, Shi X, Zhao Y, Wei H, Sun Q, Huang T, Zhang X, Wang Y.
    Vaccine; 2011 Nov 03; 29(47):8549-56. PubMed ID: 21945253
    [Abstract] [Full Text] [Related]

  • 2. Preparation and immunological effectiveness of a Swine influenza DNA vaccine encapsulated in PLGA microspheres.
    Zhao K, Li GX, Jin YY, Wei HX, Sun QS, Huang TT, Wang YF, Tong GZ.
    J Microencapsul; 2010 Nov 03; 27(2):178-86. PubMed ID: 20121488
    [Abstract] [Full Text] [Related]

  • 3. Immunization with a low dose of hemagglutinin-encoding plasmid protects against 2009 H1N1 pandemic influenza virus in mice.
    Fang J, Chen Z, Liu X, Li H, Wang J, Shen X, Chen W, Liu Y, Wang Y, Zhao P, Qi Z.
    J Virol Methods; 2011 May 03; 173(2):314-9. PubMed ID: 21392537
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cross-protection against influenza virus infection by intranasal administration of M2-based vaccine with chitosan as an adjuvant.
    Sui Z, Chen Q, Wu R, Zhang H, Zheng M, Wang H, Chen Z.
    Arch Virol; 2010 Apr 03; 155(4):535-44. PubMed ID: 20195654
    [Abstract] [Full Text] [Related]

  • 6. N-trimethyl chitosan (TMC) nanoparticles loaded with influenza subunit antigen for intranasal vaccination: biological properties and immunogenicity in a mouse model.
    Amidi M, Romeijn SG, Verhoef JC, Junginger HE, Bungener L, Huckriede A, Crommelin DJ, Jiskoot W.
    Vaccine; 2007 Jan 02; 25(1):144-53. PubMed ID: 16973248
    [Abstract] [Full Text] [Related]

  • 7. Cross-protection against influenza virus infection by intranasal administration of M1-based vaccine with chitosan as an adjuvant.
    Sui Z, Chen Q, Fang F, Zheng M, Chen Z.
    Vaccine; 2010 Nov 10; 28(48):7690-8. PubMed ID: 20870054
    [Abstract] [Full Text] [Related]

  • 8. Codon-optimization of the hemagglutinin gene from the novel swine origin H1N1 influenza virus has differential effects on CD4(+) T-cell responses and immune effector mechanisms following DNA electroporation in mice.
    Tenbusch M, Grunwald T, Niezold T, Storcksdieck Genannt Bonsmann M, Hannaman D, Norley S, Uberla K.
    Vaccine; 2010 Apr 26; 28(19):3273-7. PubMed ID: 20206668
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of seasonal pandemic influenza hemagglutinin DNA vaccines delivered by electroporation against a seasonal H1N1 virus challenge in mice.
    Tan L, Lu H, Zhang D, Wang K, Tian M, Liu C, Liu Y, Hu B, Jin N.
    Sci China Life Sci; 2011 Apr 26; 54(4):293-9. PubMed ID: 21416231
    [Abstract] [Full Text] [Related]

  • 10. Enhanced immune response and protective efficacy of a Treponema pallidum Tp92 DNA vaccine vectored by chitosan nanoparticles and adjuvanted with IL-2.
    Zhao F, Wu Y, Zhang X, Yu J, Gu W, Liu S, Zeng T, Zhang Y, Wang S.
    Hum Vaccin; 2011 Oct 26; 7(10):1083-9. PubMed ID: 21941092
    [Abstract] [Full Text] [Related]

  • 11. Intranasal chitosan-DNA vaccines that protect across influenza virus subtypes.
    Sawaengsak C, Mori Y, Yamanishi K, Srimanote P, Chaicumpa W, Mitrevej A, Sinchaipanid N.
    Int J Pharm; 2014 Oct 01; 473(1-2):113-25. PubMed ID: 24998507
    [Abstract] [Full Text] [Related]

  • 12. Plasmid DNA loaded chitosan nanoparticles for nasal mucosal immunization against hepatitis B.
    Khatri K, Goyal AK, Gupta PN, Mishra N, Vyas SP.
    Int J Pharm; 2008 Apr 16; 354(1-2):235-41. PubMed ID: 18182259
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Complete protection against a H5N2 avian influenza virus by a DNA vaccine expressing a fusion protein of H1N1 HA and M2e.
    Park KS, Seo YB, Lee JY, Im SJ, Seo SH, Song MS, Choi YK, Sung YC.
    Vaccine; 2011 Jul 26; 29(33):5481-7. PubMed ID: 21664216
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Prototype development and preclinical immunogenicity analysis of a novel minimally invasive electroporation device.
    Broderick KE, Shen X, Soderholm J, Lin F, McCoy J, Khan AS, Yan J, Morrow MP, Patel A, Kobinger GP, Kemmerrer S, Weiner DB, Sardesai NY.
    Gene Ther; 2011 Mar 26; 18(3):258-65. PubMed ID: 20962869
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.